by guojie | Mar 31, 2021 | Insights
Author: Ginger Ding At the end of 2020, as IPOs and China cross-border transactions reached a record high, Overland Pharmaceuticals announced joint ventures with ADC Therapeutics and Allogene. This announcement occurred just a week after Overland’s debut. The... by guojie | Mar 31, 2021 | Insights
Author: HE Sheng In China, licensing in has become a key link in the new drug research and development industry chain. Licensing is when one company gives another company permission for a specific period of time to manufacture its product in return for an...